Michaela Oconnell

Michaela OConnell is a skilled professional in clinical research and trial management, currently serving as a Senior Clinical Trial Associate at Fusion Pharmaceuticals since February 2024. Previously, Michaela worked at ImmunoGen, Inc. as a Clinical Trial Associate, contributing to the Phase 3 GLORIOSA study focused on treatment for specific ovarian cancers. Experience also includes positions at Dana-Farber Cancer Institute as a Clinical Research Assistant, and roles in pediatric care at Tufts Medical Center and Perkins School for the Blind. Michaela holds a Master's Degree in Clinical/Medical Laboratory Science from Massachusetts College of Pharmacy and Health Sciences and a Bachelor's Degree in Communication Sciences and Disorders from the University of Vermont.